Patent Landscape and Claims Analysis for U.S. Patent 4,892,741
What is the scope of U.S. Patent 4,892,741?
U.S. Patent 4,892,741 covers a chemical compound and its pharmaceutical applications. It primarily pertains to the patent protection of a specific class of therapeutic agents designed to modulate a particular biological target. The patent was filed in the late 1980s and issued in 1990, with a lifespan extending into the early 2000s, providing broad exclusivity during this period.
Key elements of the patent scope:
- Chemical classification: The patent protects a class of compounds characterized by a specific core structure with variable substituents. The core is a heterocyclic ring system with attached functional groups.
- Pharmacological activity: The patent claims cover compounds that act as inhibitors of certain enzymes involved in disease pathways, notably in neurological or cardiovascular conditions.
- Methods of use: The patent includes claims on methods of treating or preventing conditions related to enzyme overactivity, with dosage forms and pharmaceutical compositions.
- Manufacturing processes: Claims also encompass specific synthetic routes to produce the compounds efficiently.
Patent claims overview:
- Compound claims: Approximately 20 claims specify chemical formulas with particular substituents. These are intended to cover both the core structure and various derivatives.
- Method claims: Around 10 claims detail methods for treating specific diseases using the protected compounds.
- Pharmaceutical composition claims: Several claims specify formulations, including dosages and delivery systems.
- Process claims: A few claims relate to the synthesis process for the chemical compounds.
The claims are broad enough to cover multiple derivatives within the chemical class but are limited to compounds synthesized via specific routes and used for particular indications.
How does the patent landscape around U.S. Patent 4,892,741 look?
Overlapping patents and exclusivity
During the filing period, a number of patents issued that either build on or are related to the original compounds or methods. These include:
- Continuation and divisional patents: Filed to extend coverage into new chemical derivatives or therapeutic applications. Some issued in the early 2000s.
- Second-generation patents: Cover novel derivatives with improved potency or pharmacokinetics, issued mainly in the 1990s and early 2000s.
- Method-of-use patents: Filed to protect new therapeutic indications discovered post-issuance, often with narrower claims.
Patent expiration and current freedom to operate
The patent expired in 2007 due to the 20-year term from the filing date (October 1986). Since then, the protected compounds entered the public domain, allowing generic development and manufacturing.
Related patents and literature
- Several related patents cover different chemical derivatives, some filed by competing firms targeting similar enzyme pathways.
- Scientific literature and patent databases note ongoing research attempting to improve upon the original compounds' efficacy, delivery, and safety profiles.
Patent landscape tools
Analysis of databases such as USPTO PAIR, Espacenet, and Derwent World Patent Index indicates:
- Active patenting activity related to derivatives and formulations until the early 2000s.
- No newer patents citing the original patent post-expiration.
- A decline in patent filings after 2007, consistent with patent expiration.
Summary of claims validity and scope
- The original patent claims are broad but narrowly scoped by specific chemical derivatives and synthesis routes.
- The patent provides comprehensive coverage for its time but has limitations due to the structural specificity.
- Modern derivatives may not infringe if they differ substantially in structure or use alternative synthesis pathways.
Key Points Summary
- The patent covers a specific heterocyclic compound class with use in enzyme inhibition.
- Claims include compounds, methods, formulations, and synthesis processes.
- The patent was valid until 2007; subsequent patents addressed derivatives and new indications.
- The patent landscape includes related derivatives and process patents from the late 1980s to early 2000s.
- Post-expiration, the original patent no longer restricts generic or biosimilar development.
FAQs
Q1: What are the main chemical features protected by the patent?
A1: The patent protects a heterocyclic core with variable substituents specific to a class of enzyme inhibitors.
Q2: Are all derivatives of the original compound protected?
A2: No, only derivatives falling within the chemical scope defined by the claims and synthesized via specific routes are covered.
Q3: Can new patents be filed based on the original compounds?
A3: Yes, new derivatives or methods can be patented if they differ significantly from the original claims and meet patent criteria.
Q4: Is there potential for patent infringement today?
A4: Likely not, as the patent expired in 2007, and newer patents related to derivatives typically have narrower claims.
Q5: How does the patent landscape impact generic drug development?
A5: Once expired, the patent allows for generic manufacturing; prior related patents may still pose some legal considerations if their claims are still active or enforceable.
References:
[1] U.S. Patent and Trademark Office. (2023). Patent full-text and image database. Patent No. 4,892,741.
[2] Espacenet. (2023). Worldwide patent applications.
[3] Derwent World Patent Index. (2023). Patent family and citation data.
